Dr. William Jay Hyman, MD

Dr. Hyman practices at Saint Francis Hospital in Tulsa, Oklahoma, part of Saint Francis Health System.

Dr. Hyman's NPI, 1306889340, was assigned on June 14, 2006. Dr. Hyman graduated from Baylor College Of Medicine in 1985. Dr. Hyman holds Texas license H0482.

Dr. Hyman's primary practice is Saint Francis Hospital, at 6161 South Yale, Tulsa, OK 74136 in Tulsa County. The practice phone is (918) 494-8467.

Dr. Hyman's primary practice is Saint Francis Hospital in Tulsa, Oklahoma, part of Saint Francis Health System. Dr. Hyman is also affiliated with Texoma Medical Center. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Hyman to 1 more hospital and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hyman practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Hyman's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Hyman is board certified in hospice and palliative medicine by the American Board of Internal Medicine. Dmand AI has Dr. Hyman's licenses on file in 2 states: Texas and Ohio.

Dmand AI lists anemia, breast cancer, colorectal cancer, lung cancer and prostate cancer among the conditions Dr. Hyman treats.

CMS data shows 289 Medicare services from Dr. Hyman across 3 procedure codes in 2024, for 66 Medicare patients. Medicare paid $25,254 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 66 Medicare patients who saw Dr. Hyman in 2024. The largest group is 65 to 74, with 35 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 3.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hyman's median patient age at 63, with 21% women.

In 2024, Dr. Hyman wrote 148 Medicare Part D claims for 48 patients. 89% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $440 in total drug cost. In 2022, CMS named 26 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Hyman for performance year 2024, reported as part of a group. Dr. Hyman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Hyman, published from 2009 to 2011. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms and Docetaxel. Dr. Hyman has published most often in J Clin Oncol. Dr. Hyman's most frequent co-authors are Joanne Lorraine Blum, MD, James H. Bordelon, MD and Kristi Jo McIntyre, MD.

Dmand AI links Dr. Hyman to 1 clinical trial. Conditions studied include Breast Neoplasms and Breast Diseases.

CMS Open Payments shows 63 general payments to Dr. Hyman from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 74% of the total. Daiichi Sankyo Inc. paid the most, $1,002.

Dr. Hyman graduated from Baylor College Of Medicine in 1985. Dr. Hyman is a member of American Board of Internal Medicine-ABIM, ACP and ASCO.

Dr. Hyman is in network with 18 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.